Bosh sahifaORCHPHARMA • NSE
add
Orchid Pharma Ltd
Yopilish kursi
720,25 ₹
Kunlik diapazon
710,40 ₹ - 729,00 ₹
Yillik diapazon
603,80 ₹ - 1 997,40 ₹
Bozor kapitalizatsiyasi
36,19 mlrd INR
Oʻrtacha hajm
106,02 ming
Narx/foyda
42,45
Dividend daromadliligi
-
Asosiy maydon
NSE
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (INR) | iyn, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 1,73 mlrd | -29,25% |
Joriy xarajat | 685,42 mln | -2,23% |
Sof foyda | 149,11 mln | -49,20% |
Sof foyda marjasi | 8,62 | -28,23% |
Har bir ulushga tushum | — | — |
EBITDA | 141,58 mln | -55,75% |
Amaldagi soliq stavkasi | — | — |
Balans
Jami aktivlari
Jami passivlari
| (INR) | iyn, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 1,80 mlrd | 4 871,20% |
Jami aktivlari | — | — |
Jami passivlari | — | — |
Umumiy kapital | 12,67 mlrd | — |
Tarqatilgan aksiyalar | 50,72 mln | — |
Narxi/balansdagi bahosi | 2,88 | — |
Aktivlardan daromad | — | — |
Kapitaldan daromad | 0,96% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (INR) | iyn, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 149,11 mln | -49,20% |
Operatsiyalardan naqd pul | — | — |
Sarmoyadan naqd pul | — | — |
Moliyadan naqd pul | — | — |
Naqd pulning sof oʻzgarishi | — | — |
Boʻsh pul | — | — |
Haqida
Orchid Pharma Limited is an Indian pharmaceutical company based in Chennai, founded on 1 July 1992. As of 2024, it was among the top fortune 500 Indian companies by market capitalization. Orchid Pharma is the only pharma company in India to have discovered a New Drug Enmetazobactam which is now approved in United States, Europe and India. Wikipedia
Tashkil etilgan
1992
Sayt
Xodimlar soni
736
